References
- Lemke TL, Williams DA. (2008). Foye’s Principles of Medicinal Chemistry. Baltimore and Philadelphia: Lippincott Williams & Wilkins USA, 99–391.
- Silverman RB. (2004). The organic chemistry of drug design and drug action. Burlington: Elsevier Academic Press USA, 229–535.
- Shen ZX. Brain cholinesterases: III. Future perspectives of AD research and clinical practice. Med Hypotheses 2004;63:298–307.
- Wilkinson DG, Francis PT, Schwam E, Payne-Parrish J. Cholinesterase inhibitors used in the treatment of Alzheimer’s disease: the relationship between pharmacological effects and clinical efficacy. Drugs Aging 2004;21:453–478.
- Grutzendler J, Morris JC. Cholinesterase inhibitors for Alzheimer’s disease. Drugs 2001;61:41–52.
- Giacobini E. Cholinesterases: new roles in brain function and in Alzheimer’s disease. Neurochem Res 2003;28:515–522.
- Johannsen P. Long-term cholinesterase inhibitor treatment of Alzheimer’s disease. CNS Drugs 2004;18:757–768.
- Martinez A, Castro A. Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer’s disease. Expert Opin Investig Drugs 2006;15:1–12.
- Pepeu G, Giovannini MG. Cholinesterase inhibitors and beyond. Curr Alzheimer Res 2009;6:86–96.
- Siddiqui N, Arshad MF, Ahsan W, Alam MS. Thiazoles: a valuable insight into the recent advances and biological activities. Int J Pharm Sci Drug Res 2009;1:136–143.
- Mustafa SM, Naira VA, Chittoorb JP, Krishnapillaic S. Synthesis of 1,2,4-Triazoles and thiazoles from thiosemicarbazide and its derivatives. Mini-Rev Org Chem 2004;1:375–385.
- Andreani A, Burnelli S, Granaiola M, Guardigli M, Leoni A, Locatelli A et al. Chemiluminescent high-throughput microassay applied to imidazo[2,1-b]thiazole derivatives as potential acetylcholinesterase and butyrylcholinesterase inhibitors. Eur J Med Chem 2008;43:657–661.
- Sengupta AK, Garg M. New 5-arylamino-2[N-(2′-mercaptoacetylamino-4′-arylthiazolo)]thiadiazoles(III): as AChE inhibitors. J Indian Chem Soc 1980;57:1241–1243.
- Shaw FH, Bentley GA. The pharmacology of some new anti-cholinesterases. Aust J Exp Biol Med Sci 1953;31:573–576.
- Matsunaga Y, Tanaka T, Yoshinaga K, Ueki S, Hori Y, Eta R et al. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride. J Pharmacol Exp Ther 2011;336:791–800.
- Alspach JD, Ingraham LL. Inhibition of acetylcholinesterase by thiamine. A structure-function study. J Med Chem 1977;20:161–164.
- Tomassoli I, Ismaili L, Pudlo M, de Los Rí, os C, Soriano E, Colmena I et al. Synthesis, biological assessment and molecular modeling of new dihydroquinoline-3-carboxamides and dihydroquinoline-3-carbohydrazide derivatives as cholinesterase inhibitors, and Ca channel antagonists. Eur J Med Chem 2011;46:1–10.
- Cakir B, Yildirim E, Ercanli T, Erol K, Sahin MF. Synthesis and anticonvulsant activity of some (2/4-substituted)benzaldehyde (2-oxobenzothiazolin-3-yl)acetohydrazones. Farmaco 1999;54:842–845.
- Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.
- Mossmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63.
- Keiser K, Johnson CC, Tipton DA. Cytotoxicity of mineral trioxide aggregate using human periodontal ligament fibroblasts. J Endod 2000;26:288–291.
- Altintop MD, Kaplancikli ZA, Ozdemir A, Turan-Zitouni G, Temel HE, Akalın G. Synthesis and anticholinesterase activity and cytotoxicity of novel amide derivatives. Arch Pharm 2011. DOI: 10.1002/ardp.201100124.